4
|
Wee LWY, Tan EC, Bishnoi P, Ng YZ, Lunny DP, Lim HW, Lee SP, Ong C, Yap TL, Mok YH, Low MY, Chu-Tian Chow C, Derrick L, Common JEA, Birgitte Lane E, Koh MJA. Epidermolysis bullosa with pyloric atresia associated with compound heterozygous ITGB4 pathogenic variants: Minimal skin involvement but severe mucocutaneous disease. Pediatr Dermatol 2021; 38:908-912. [PMID: 34152038 DOI: 10.1111/pde.14668] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
We report a case of junctional epidermolysis bullosa with pyloric atresia (JEB-PA) with minimal skin involvement but severe protein-losing enteropathy and airway involvement. Genetic analysis revealed heterozygous mutations in the ITGB4 gene encoding integrin β4 protein. Parental testing confirmed inheritance of frameshift variant (c.794dupC) as maternal and splice site variant (c.1608C>T/p.Cys536Cys) as paternal. Immunofluorescence mapping of her skin revealed a subepidermal blister with decreased and frayed integrin β4 at both the floor and the roof of the blister, while the intestinal mucosa showed complete absence of integrin β4. We review the literature and discuss the differential expression of integrins in the skin and gastrointestinal tract, as well as the role of chronic inflammation in the pathogenesis of EB.
Collapse
Affiliation(s)
- Lynette Wei Yi Wee
- Dermatology Service, KK Women's and Children's Hospital, Singapore, Singapore
| | - Ene Choo Tan
- Research Laboratory, KK Women's and Children's Hospital, Singapore, Singapore.,Genetics Service, KK Women's and Children's Hospital, Singapore, Singapore
| | - Priya Bishnoi
- Dermatology Service, KK Women's and Children's Hospital, Singapore, Singapore
| | - Yi Zhen Ng
- Institute of Medical Biology and Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
| | - Declan Patrick Lunny
- Institute of Medical Biology and Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
| | - Hwee-Woon Lim
- Research Laboratory, KK Women's and Children's Hospital, Singapore, Singapore
| | - Siew-Peng Lee
- Research Laboratory, KK Women's and Children's Hospital, Singapore, Singapore
| | - Christina Ong
- Paediatric Gastroenterology, KK Women's and Children's Hospital, Singapore, Singapore
| | - Te Lu Yap
- Paediatric Surgery, KK Women's and Children's Hospital, Singapore, Singapore
| | - Yee Hui Mok
- Children's Intensive Care, KK Women's and Children's Hospital, Singapore, Singapore
| | - Mei Yi Low
- Paediatric ENT, KK Women's and Children's Hospital, Singapore, Singapore
| | | | - Lian Derrick
- Department of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore, Singapore
| | - John Edmund Armourer Common
- Institute of Medical Biology and Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
| | - Ellen Birgitte Lane
- Institute of Medical Biology and Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
| | - Mark Jean Aan Koh
- Dermatology Service, KK Women's and Children's Hospital, Singapore, Singapore
| |
Collapse
|
5
|
De Arcangelis A, Hamade H, Alpy F, Normand S, Bruyère E, Lefebvre O, Méchine-Neuville A, Siebert S, Pfister V, Lepage P, Laquerriere P, Dembele D, Delanoye-Crespin A, Rodius S, Robine S, Kedinger M, Van Seuningen I, Simon-Assmann P, Chamaillard M, Labouesse M, Georges-Labouesse E. Hemidesmosome integrity protects the colon against colitis and colorectal cancer. Gut 2017; 66:1748-1760. [PMID: 27371534 PMCID: PMC5595104 DOI: 10.1136/gutjnl-2015-310847] [Citation(s) in RCA: 62] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2015] [Revised: 05/12/2016] [Accepted: 05/30/2016] [Indexed: 12/12/2022]
Abstract
OBJECTIVE Epidemiological and clinical data indicate that patients suffering from IBD with long-standing colitis display a higher risk to develop colorectal high-grade dysplasia. Whereas carcinoma invasion and metastasis rely on basement membrane (BM) disruption, experimental evidence is lacking regarding the potential contribution of epithelial cell/BM anchorage on inflammation onset and subsequent neoplastic transformation of inflammatory lesions. Herein, we analyse the role of the α6β4 integrin receptor found in hemidesmosomes that attach intestinal epithelial cells (IECs) to the laminin-containing BM. DESIGN We developed new mouse models inducing IEC-specific ablation of α6 integrin either during development (α6ΔIEC) or in adults (α6ΔIEC-TAM). RESULTS Strikingly, all α6ΔIEC mutant mice spontaneously developed long-standing colitis, which degenerated overtime into infiltrating adenocarcinoma. The sequence of events leading to disease onset entails hemidesmosome disruption, BM detachment, IL-18 overproduction by IECs, hyperplasia and enhanced intestinal permeability. Likewise, IEC-specific ablation of α6 integrin induced in adult mice (α6ΔIEC-TAM) resulted in fully penetrant colitis and tumour progression. Whereas broad-spectrum antibiotic treatment lowered tissue pathology and IL-1β secretion from infiltrating myeloid cells, it failed to reduce Th1 and Th17 response. Interestingly, while the initial intestinal inflammation occurred independently of the adaptive immune system, tumourigenesis required B and T lymphocyte activation. CONCLUSIONS We provide for the first time evidence that loss of IECs/BM interactions triggered by hemidesmosome disruption initiates the development of inflammatory lesions that progress into high-grade dysplasia and carcinoma. Colorectal neoplasia in our mouse models resemble that seen in patients with IBD, making them highly attractive for discovering more efficient therapies.
Collapse
Affiliation(s)
- Adèle De Arcangelis
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France
| | - Hussein Hamade
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France,Current address: F. Widjaja Foundation Inflammatory Bowel & Immunobiology Research Institute, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA
| | - Fabien Alpy
- Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France,Inserm, U1109, MNT3 Team, Strasbourg, France,Current address: Department of Functional Genomics and Cancer, IGBMC, Illkirch, France
| | - Sylvain Normand
- CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019—UMR 8204—CIIL—Centre d'Infection et d'Immunité de Lille, Université de Lille, Lille, France
| | - Emilie Bruyère
- Inserm, Université de Lille, CHRU Lille, UMR-S 1172—Jean-Pierre Aubert Research Center, Lille, France
| | - Olivier Lefebvre
- Université de Strasbourg, Strasbourg, France,Inserm, U1109, MNT3 Team, Strasbourg, France,LabEx Medalis, Université de Strasbourg, Strasbourg, France,Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
| | - Agnès Méchine-Neuville
- Inserm, U1109, MNT3 Team, Strasbourg, France,CHRU Strasbourg, Hôpital de Hautepierre, Service d'anatomo-pathologie, Strasbourg, France,Current address: Département de Pathologie, Institut Bergonie, Bordeaux, France
| | - Stéphanie Siebert
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France
| | - Véronique Pfister
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France
| | - Patricia Lepage
- UMR1319—MICALIS Institute, INRA, AgroParisTech,Université Paris-Saclay, Jouy-en-Josas, France
| | - Patrice Laquerriere
- Université de Strasbourg, Strasbourg, France,CNRS, UMR 7178, Institut Pluridisciplinaire Hubert Curien,Strasbourg, France
| | - Doulaye Dembele
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France
| | - Anne Delanoye-Crespin
- CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019—UMR 8204—CIIL—Centre d'Infection et d'Immunité de Lille, Université de Lille, Lille, France
| | - Sophie Rodius
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France,Current address: NORLUX Neuro-Oncology Laboratory, CRP-Santé, Luxembourg
| | - Sylvie Robine
- Institut Curie, Paris, France,CNRS, UMR 144, Paris, France
| | - Michèle Kedinger
- Université de Strasbourg, Strasbourg, France,Inserm, U1109, MNT3 Team, Strasbourg, France
| | - Isabelle Van Seuningen
- Inserm, Université de Lille, CHRU Lille, UMR-S 1172—Jean-Pierre Aubert Research Center, Lille, France
| | - Patricia Simon-Assmann
- Université de Strasbourg, Strasbourg, France,Inserm, U1109, MNT3 Team, Strasbourg, France,LabEx Medalis, Université de Strasbourg, Strasbourg, France,Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France
| | - Mathias Chamaillard
- CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019—UMR 8204—CIIL—Centre d'Infection et d'Immunité de Lille, Université de Lille, Lille, France
| | - Michel Labouesse
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France,Current address: UMR7622, IBPS, Université Pierre et Marie Curie, Paris, France
| | - Elisabeth Georges-Labouesse
- Department of Development and Stem Cells, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg, Illkirch, France,Inserm, U964, Illkirch, France,CNRS, UMR 7104, Illkirch, France,Université de Strasbourg, Strasbourg, France
| |
Collapse
|